A 35-year-old man is brought to the emergency department 2 hours after ingesting an unknown quantity of heroin. He presents with severe respiratory depression (RR 6/min), pinpoint pupils, and altered consciousness. After securing the airway and initiating bag-mask ventilation, naloxone is administered intravenously. Which investigation is most appropriate to confirm opioid toxicity and guide further management?

Explanation

## Investigation of Choice to Confirm Opioid Toxicity and Guide Management ### Clinical Context This patient presents with the classic opioid toxidrome: respiratory depression (RR 6/min), miosis (pinpoint pupils), and altered mental status following heroin ingestion. The stem asks for the investigation most appropriate to **confirm opioid toxicity** and guide further management. ### Why Urine Immunoassay for Opioids is the Best Investigation **Key Point:** Urine immunoassay (urine drug screen) is the most appropriate investigation because it: 1. **Directly confirms opioid exposure** — provides qualitative evidence of opioid presence, establishing the toxicological diagnosis 2. **Rapidly available** — results in 15–30 minutes in most emergency settings; point-of-care testing is widely accessible 3. **Guides management decisions** — confirms the appropriateness of continued naloxone therapy and helps exclude co-ingestion of other substances 4. **Standard of care** — recommended by toxicology guidelines (Goldfrank's Toxicologic Emergencies) as the first-line confirmatory test in suspected opioid overdose ### Why Other Options Are Suboptimal | Investigation | Limitation | |---|---| | **ABG analysis** | Assesses severity of respiratory compromise and acid-base status but does NOT confirm the specific etiology (opioid toxicity); it is a supportive/prognostic tool, not a confirmatory diagnostic test | | **Serum morphine HPLC** | Highly specific but requires 4–6+ hours; not available in the acute emergency setting; serum levels correlate poorly with clinical toxicity; not practical for immediate decision-making | | **Pupillometer assessment** | Useful for monitoring response to naloxone but is a clinical tool, not a laboratory investigation; does not confirm opioid exposure biochemically | **High-Yield:** The stem specifically asks to **confirm opioid toxicity** — urine immunoassay is the investigation that directly answers this question. ABG is valuable for assessing severity but does not confirm the diagnosis. **Clinical Pearl:** Urine immunoassay detects opioids (morphine, codeine, heroin metabolites) for up to 2–4 days after use. A positive result in the context of the clinical toxidrome confirms opioid overdose and supports continued naloxone administration. Note that synthetic opioids (fentanyl, methadone) may require specific immunoassay panels. **Warning:** A negative standard urine immunoassay does not exclude synthetic opioid toxicity (e.g., fentanyl), as these may not cross-react with standard morphine-based assays. Clinical judgment remains paramount. *Reference: Goldfrank's Toxicologic Emergencies, 11th edition; Harrison's Principles of Internal Medicine, 21st edition.*